1.

Record Nr.

UNINA9910789961503321

Autore

Tobbell Dominique A. <1978-, >

Titolo

Pills, Power, and Policy : The Struggle for Drug Reform in Cold War America and Its Consequences / / Dominique Tobbell

Pubbl/distr/stampa

Berkeley, CA : , : University of California Press, , [2011]

©2011

ISBN

1-280-11677-3

9786613521064

0-520-95242-1

Descrizione fisica

1 online resource (311 p.)

Collana

California/Milbank Books on Health and the Public ; ; 23

Disciplina

338.4/76151

338.476151

Soggetti

Drug Industry -- history -- United States

Drugs -- Research -- United States -- History -- 20th century

Economics, Pharmaceutical -- United States

History, 20th Century -- United States

Pharmaceutical industry - United States - History - 20th century

Drugs - Research - History - 20th century - United States

Pharmaceutical industry - History - 20th century - United States

Economics

History, Modern 1601-

Humanities

Industry

Health Care Economics and Organizations

Technology, Industry, and Agriculture

Health Care

Drug Industry

Economics, Pharmaceutical

History, 20th Century

History

North America

Americas

Geographic Locations

United States

Lingua di pubblicazione

Inglese



Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di contenuto

Front matter -- Contents -- Foreword -- Acknowledgments -- Introduction: Pharmaceutical Politics, Then and Now -- 1. Knowledgeable Relations: The Building of a Pharmaceutical Research Network -- 2. Workforce Relations: The Invention of the Pharmaceutical Postdoctoral Fellowship -- 3. Professional Relations: Crafting the Public Image of the Health Care Team -- 4. Cold War Alliances: Kefauver's Bid for Pharmaceutical Reform -- 5. Expert Alliances: The Creation of the Drug Research Board -- 6. Generic Alliances and the Backlash against Regulatory Reform -- Epilogue -- Notes -- Bibliography -- Index

Sommario/riassunto

Since the 1950's, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation. Pills, Power, and Policy offers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic researchers, the book provides essential historical context for understanding how corporate interests came to dominate American health care policy after World War II.